| simultaneous pancreas kidney transplantation: initial experience of the emory university transplant service. | the successful replacement of islet tissue by pancreas transplantation appears to be beneficial in the early course of those uremic diabetic recipients who receive a simultaneous renal transplant. the long-term advantages of skp transplantation remain to be determined, however, current improvement in patient and graft survival following spk and the difficulties thus far reported in islet cell transplantation have renewed clinical interests in spk, pak and pa transplantation. in our experience, p ... | 1994 | 7928160 |
| methodology of a multistate study of congenital hearing loss: preliminary data from utah newborn screening. | a multistate centers for disease control and prevention (cdc) study was designed to investigate the etiology of congenital hearing loss in infants ascertained through state-mandated hearing screening or early hearing loss detection and intervention (ehdi) programs. at least 50% of permanent childhood-onset hearing loss is due to genetic causes, and approximately 20% of all infants with congenital hearing loss have mutations in the gjb2 gene. another 1% of childhood hearing loss is due to mitocho ... | 2004 | 14755431 |
| glycoprotein b subtyping of cytomegalovirus (cmv) in the vitreous of patients with aids and cmv retinitis. | a 550-bp region of the cytomegalovirus (cmv) glycoprotein b (gb) gene was amplified by polymerase chain reaction (pcr) from 141 vitreous specimens of 120 patients with aids and cmv retinitis from three different metropolitan centers. the distribution of gb subtypes i, ii, iii, and iv were 19%, 43%, 12%, and 21%, respectively, based on restriction enzyme digestion patterns of pcr-amplified dna. two patients had simultaneous infection with two different gb subtypes. the ratio of gb subtypes was si ... | 1998 | 9806048 |
| prevalence of invasive cytomegalovirus disease with administration of muromonab cd-3 in patients undergoing orthotopic liver transplantation. | to assess the association of cytomegalovirus (cmv) disease with the administration of muromonab cd-3 (okt-3) in patients undergoing liver transplant; specifically, to assess the risk of okt-3 use as an agent for rejection prophylaxis and as an agent for therapy of rejection. | 1992 | 1317228 |